Rich Yang

If you don't finger stick often enough and if you're not using conventional CGM and it's not reimbursed for conventional CGM, well, what can we do to help with metabolic health literacy?

And one sensor a year, one sensor a quarter, one sensor per month.

What is that schema?

So these are the things that we're attempting to answer in the near future.

whatever it takes to mitigate disease progression.

And there's a window of time to reverse type two diabetes.

And this could be a very important tool in the fight against diabetes.

So we have a design philosophy to develop products that are specific to the indication.

So for our future product pipeline coming,

For people that use insulin, we would have the numbers, the trends, the graphs similar to all the other CGM.

So our products will be designed specific to the indication.

So the metabolic health literacy is still far too low.

And if we could raise that bar, then how much can we save health systems, right?

So if we can find the 20% of people that are consuming 80% of the costs, this is one of the non-invasive tools, needle-free, that could be deployed mainstream.

Mm-hmm.

And so you'll find that the first year of our commercial efforts will be used to really tailor that real-world evidence and the feedback that we're getting from users and to really drive the right protocols on the frequency of wear that would derive the greatest benefit.

Yeah.

You can imagine we don't have time for organic scale.

So the use of capital and the use of funds, we raised $100 million Series C financing and the large bulk of the capital that we raised will go towards manufacturing scale in the foreseeable future.

We have to hyperscale from day one.